BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32505611)

  • 1. The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials.
    Ribatti D; Annese T; Tamma R
    Microvasc Res; 2020 Sep; 131():104026. PubMed ID: 32505611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay.
    Azzarello J; Ihnat MA; Kropp BP; Warnke LA; Lin HK
    Biomed Mater; 2007 Jun; 2(2):55-61. PubMed ID: 18458436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids.
    Ribatti D
    Microvasc Res; 2022 Mar; 140():104304. PubMed ID: 34906560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chick embryo chorioallantoic membrane patient-derived xenograft (PDX) model.
    Ribatti D
    Pathol Res Pract; 2023 Mar; 243():154367. PubMed ID: 36774760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chick chorioallantoic membrane as an in vivo angiogenesis model.
    Ponce ML; Kleinmann HK
    Curr Protoc Cell Biol; 2003 May; Chapter 19():Unit 19.5. PubMed ID: 18228425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chicken chorioallantoic membrane angiogenesis model.
    Ribatti D
    Methods Mol Biol; 2012; 843():47-57. PubMed ID: 22222520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.
    Ribatti D
    Int Rev Cell Mol Biol; 2008; 270():181-224. PubMed ID: 19081537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chick embryo chorioallantoic membrane (CAM) assay.
    Ribatti D
    Reprod Toxicol; 2017 Jun; 70():97-101. PubMed ID: 27832950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
    As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
    Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.
    Kennedy DC; Coen B; Wheatley AM; McCullagh KJA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the chick embryo chorioallantoic membrane in neurosurgery disease.
    Yuan YJ; Xu K; Wu W; Luo Q; Yu JL
    Int J Med Sci; 2014; 11(12):1275-81. PubMed ID: 25419173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluronic F127 as a drug vehicle used in chick embryo chorioallantoic membrane shell-less model.
    Shi T; Li Z; Zhang Q; Zheng D; Li Z
    Pak J Pharm Sci; 2015 Nov; 28(6):1997-9. PubMed ID: 26639476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
    Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
    Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex ova chick chorioallantoic membrane as a novel model for evaluation of tissue responses to biomaterials and implants.
    Klueh U; Dorsky DI; Moussy F; Kreutzer DL
    J Biomed Mater Res A; 2003 Dec; 67(3):838-43. PubMed ID: 14613232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo angiogenic activity of erythropoietin.
    Ribatti D
    Methods Mol Biol; 2013; 982():227-35. PubMed ID: 23456873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of vascular colonisation and angio-conduction in porous silicon-substituted hydroxyapatite with various pore shapes in a chick chorioallantoic membrane (CAM) model.
    Magnaudeix A; Usseglio J; Lasgorceix M; Lalloue F; Damia C; Brie J; Pascaud-Mathieu P; Champion E
    Acta Biomater; 2016 Jul; 38():179-89. PubMed ID: 27131570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of collateral vessels: A new paradigm in CAM angiogenesis model.
    Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN
    Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choline promotes angiogenesis in chick embryo chorioallantoic membrane].
    Wang H; Zeng XZ; Cui WY; Duan L
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 May; 29(3):229-31. PubMed ID: 23940955
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Moreno-Jiménez I; Kanczler JM; Hulsart-Billstrom G; Inglis S; Oreffo ROC
    Tissue Eng Part C Methods; 2017 Dec; 23(12):938-952. PubMed ID: 28877648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of Embryonic Macrophages Leads to a Reduction in Angiogenesis in the Ex Ovo Chick Chorioallantoic Membrane Assay.
    Tay H; Du Cheyne C; Demeyere K; De Craene J; De Bels L; Meyer E; Zijlstra A; Spiegelaere W
    Cells; 2020 Dec; 10(1):. PubMed ID: 33375076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.